Focal Spot, Fall/Winter 1997 [PDF]
https://digitalcommons.wustl.edu/focal_spot_archives/1077/thumbnail ...
core +1 more source
Focal Spot, Winter 2004/2005 [PDF]
https://digitalcommons.wustl.edu/focal_spot_archives/1098/thumbnail ...
core +1 more source
Phase i study of \u27dose-dense\u27 pemetrexed plus carboplatin/radiotherapy for locally advanced non-small cell lung carcinoma. [PDF]
BACKGROUND: This phase I study investigates the feasibility of carboplatin plus dose-dense (q2-week) pemetrexed given concurrently with radiotherapy (XRT) for locally advanced and oligometastatic non-small cell lung cancer (NSCLC).
Axelrod, Rita+8 more
core +1 more source
Beyond Concurrent Chemoradiation: The Emerging Role of PD-1/PD-L1 Inhibitors in Stage III Lung Cancer. [PDF]
Concurrent chemoradiation (cCRT) with platinum-based chemotherapy is standard-of-care therapy for patients with stage III unresectable non-small cell lung cancer (NSCLC).
Dicker, Adam P., Lu, Bo, McCall, Neal S.
core +1 more source
Conclusions: The prognosis of HCC patients receiving RT was worse for those with a pre-RT serum IL-6 concentration > 7.8 pg/mL than those with a pre-RT serum IL-6 concentration ≤ 7.8 pg/mL.
Yong Hu+5 more
doaj +1 more source
White matter changes are correlated significantly with radiation dose. Observations from a randomized dose-escalation trial for malignant glioma (radiation therapy oncology group 83-02) [PDF]
Benjamin W. Corn+7 more
openalex +1 more source
Full Issue: Volume 13, Issue 1 - Winter 2018 [PDF]
Full Issue: Volume 13, Issue 1 - Winter ...
core +1 more source
interruptions adversely affect local control and survival with hyperfractionated radiation therapy of carcinomas of the upper respiratory and digestive tracts new evidence for accelerated proliferation from radiation therapy oncology group protocol 8313 [PDF]
James D. Cox+10 more
openalex +1 more source